A61K 9/28
Dragees
Official title: Dragees; Coated pills or tablets {, e.g. with film or compression coating (A61K9/2072 takes precedence, e.g. partially coated tablets A61K9/2072, coated multilayer tablets A61K9/2086, tablets with drug-coated core A61K9/209)}
A61K9/28 (Dragees) appears on 3,410 US grants and 6,346 published applications in this corpus.
Search patents in A61K- Granted patents
- 3,410
- Published applications
- 6,346
- Assignees
- 1,929
- Inventors
- 8,986
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 7 | 0 |
| 1978 | 13 | 0 |
| 1979 | 10 | 0 |
| 1980 | 4 | 0 |
| 1981 | 13 | 0 |
| 1982 | 11 | 0 |
| 1983 | 8 | 0 |
| 1984 | 17 | 0 |
| 1985 | 16 | 0 |
| 1986 | 8 | 0 |
| 1987 | 22 | 0 |
| 1988 | 17 | 0 |
| 1989 | 22 | 0 |
| 1990 | 18 | 0 |
| 1991 | 19 | 0 |
| 1992 | 18 | 0 |
| 1993 | 18 | 0 |
| 1994 | 24 | 0 |
| 1995 | 34 | 0 |
| 1996 | 37 | 0 |
| 1997 | 46 | 0 |
| 1998 | 41 | 0 |
| 1999 | 36 | 0 |
| 2000 | 55 | 0 |
| 2001 | 61 | 24 |
| 2002 | 57 | 87 |
| 2003 | 74 | 155 |
| 2004 | 56 | 198 |
| 2005 | 36 | 226 |
| 2006 | 45 | 193 |
| 2007 | 40 | 206 |
| 2008 | 36 | 206 |
| 2009 | 38 | 224 |
| 2010 | 78 | 260 |
| 2011 | 81 | 274 |
| 2012 | 107 | 230 |
| 2013 | 165 | 299 |
| 2014 | 195 | 351 |
| 2015 | 158 | 344 |
| 2016 | 187 | 345 |
| 2017 | 207 | 346 |
| 2018 | 160 | 286 |
| 2019 | 155 | 284 |
| 2020 | 167 | 294 |
| 2021 | 175 | 292 |
| 2022 | 147 | 256 |
| 2023 | 132 | 238 |
| 2024 | 139 | 251 |
| 2025 | 115 | 250 |
| 2026 | 77 | 227 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Dosage forms for TYK2 inhibitors6 Oct 2026US 12,751,948 B2Bristol-Myers Squibb Company
- Anticancer compositions29 Sep 2026US 12,746,230 B2Aragon Pharmaceuticals, Inc.
- Delayed release compositions22 Sep 2026US 12,740,951 B2Amneal Complex Products Research LLC
- Soluble pharmaceutical compositions comprising salts of disubstituted 1, 2, 4-triazine compound22 Sep 2026US 12,740,987 B2Mineralys Therapeutics, Inc.
- Losartan-containing micro tablet for pediatric applications15 Sep 2026US 12,734,131 B2Midas Pharma GmbH
- Colonic purgative tablet and colonic purgative comprising same8 Oct 2026US 2026/0306413 A1Pharmbio Korea Co., Ltd.
- Method and pharmaceutical composition for treating a sleep disorder8 Oct 2026US 2026/0306442 A1Overseas Pharmaceuticals, Ltd.
- Use of milvexian in the treatment and prevention of thrombotic conditions in patients with atrial fibrilation8 Oct 2026US 2026/0306492 A1Bristol-Myers Squibb Company
- Natural aqueous film-forming composition based on a pair of starches1 Oct 2026US 2026/0294815 A1Swiss Applied Coating Research GmbH
- Histamine receptor agonists for cancer therapy in cancer patients unresponsive to cancer immunotherapy and with elevated myeloid derived suppressor cells1 Oct 2026US 2026/0294873 A1TSP Therapeutics Inc.
Most cited
By later US patents
- Controlled release formulations coated with aqueous dispersions of acrylic polymers1,011US 5,639,476 AEuro-Celtique S. A. · 1997
- Swelling modulated polymeric drug delivery device706US 5,120,548 AMerck & Co., Inc. · 1992
- Sustained release drug delivery devices481US 5,378,475 AUniversity of Kentucky Research Foundation · 1995
- Controlled-release formulations coated with aqueous dispersions of ethylcellulose445US 5,472,712 AEuroceltique, S.A. · 1995
- Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer438US 5,273,760 AEuroceltigue, S.A. · 1993